White Anne E.
SEC CIK 1752313 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LLY | Lilly (Eli) | SVP, Pres-Lilly Neuroscience | 74.2K | — | $1.72M | 13 | 2022-02-01 | 2025-02-10 |
Most active insiders at LLY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LILLY ENDOWMENT INC | Former 10% Shareholder | — | $3.34B |
| 2 | Jonsson Patrik | EVP, Pres, LLY Int'l | — | $7.64M |
| 3 | Hakim Anat | EVP, GC, Sec | — | $5.95M |
| 4 | Zakrowski Donald A | SVP, CAO, Fin | — | $3.38M |
| 5 | Yuffa Ilya | EVP, Pres, LLY USA, Gbl Capab | — | $2.88M |
| 6 | Brown Adrienne S | EVP, Pres LLY Imm | — | — |
| 7 | Custer Kenneth L. | EVP, Pres, Card Met Hlth | — | — |
| 8 | Seymour Melissa | EVP, Gbl Quality | — | — |
| 9 | Dozier Eric | EVP, CHRO | — | — |
| 10 | Hernandez Edgardo | EVP, Pres, Mfg. Ops | — | — |
White Anne E. made no open-market trades at LLY in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-10 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | A - Grant | $868.88 | +6,829 | 74.2K | +10% | +$5.93M |
| D | 2025-02-04 | 2025-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | F - Tax | $811.08 | -1,457 | 67.4K | -2% | -$1.18M |
| D | 2025-02-04 | 2025-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | M - OptEx | $0.00 | +3,269 | 68.8K | +5% | $0 |
| D | 2024-02-14 | 2024-02-12 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | A - Grant | $737.26 | +5,363 | 65.6K | +9% | +$3.95M |
| D | 2024-02-02 | 2024-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | M - OptEx | $0.00 | +4,124 | 62.0K | +7% | $0 |
| D | 2024-02-02 | 2024-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | F - Tax | $645.61 | -1,844 | 60.2K | -3% | -$1.19M |
| DM | 2023-02-14 | 2023-02-10+ | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | S - Sale | $344.62 | -5,000 | 57.9K | -8% | -$1.72M |
| D | 2023-02-14 | 2023-02-10 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | A - Grant | $345.12 | +8,562 | 62.9K | +16% | +$2.95M |
| D | 2023-02-03 | 2023-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | F - Tax | $344.15 | -3,252 | 54.4K | -6% | -$1.12M |
| D | 2023-02-03 | 2023-02-01 | LLY | Lilly (Eli) | White Anne E. | EVP, Pres, Lilly Neuroscience | M - OptEx | $0.00 | +7,264 | 57.6K | +14% | $0 |
| D | 2022-02-11 | 2022-02-09 | LLY | Lilly (Eli) | White Anne E. | SVP, Pres-Lilly Neuroscience | A - Grant | $243.27 | +11.3K | 50.4K | +29% | +$2.76M |
| D | 2022-02-03 | 2022-02-01 | LLY | Lilly (Eli) | White Anne E. | SVP, Pres-Lilly Neuroscience | M - OptEx | $0.00 | +9,368 | 43.2K | +28% | $0 |
| D | 2022-02-03 | 2022-02-01 | LLY | Lilly (Eli) | White Anne E. | SVP, Pres-Lilly Neuroscience | F - Tax | $245.39 | -4,204 | 39.0K | -10% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations